Carbon 60 Dissolved in Grapeseed Oil Inhibits Dextran Sodium Sulfate-Induced Experimental Colitis

References

• Yang SK. How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective. Inflamm Intest Dis. 2017;2(2):95–101.
   PubMedGoogle Scholar
• Nobrega VG, Silva INN, Brito BS, Silva J, Silva M, Santana GO. The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients. Arq Gastroenterol. 2018;55(3):290–295.
   PubMedGoogle Scholar
• Muthas D, Reznichenko A, Balendran CA, et al. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scand J Gastroenterol. 2017;52(2):125–135.
   PubMed Web of Science ®Google Scholar
• Ben-Horin S, Andrews JM, Katsanos KH, et al. Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians’ practice. World J Gastroenterol. 2017;23(16):2995–3002.
   PubMed Web of Science ®Google Scholar
• Curkovic I, Egbring M, Kullak-Ublick GA. Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Dig Dis. 2013;31(3–4):368–373.
   PubMed Web of Science ®Google Scholar
• Klein A, Eliakim R. Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease. Pharmaceuticals. 2010;3(4):1084–1092.
   Google Scholar
• Smolović B, Vučković L, Borozan S, Vukčevič B. Nonsteroidal anti-inflammatory drug-induced colopathy: an uncommon cause of positive immunochemical faecal occult blood test in the program for colorectal cancer screening. Vojnosanitetski pregled. 2021;78:1.
   Web of Science ®Google Scholar
• Innocenzi P, Stagi L. Carbon-based antiviral nanomaterials: graphene, C-dots, and fullerenes. A perspective. Chem Sci. 2020;11(26):6606–6622.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Zou Q, Xing R, Jiao T, Yan X. An injectable dipeptide-fullerene supramolecular hydrogel for photodynamic antibacterial therapy. J Mater Chem B. 2018;6(44):7335–7342.
   PubMed Web of Science ®Google Scholar
• Gudkov SV, Guryev EL, Gapeyev AB, et al. Unmodified hydrated capital ES, Cyrillic 60 fullerene molecules exhibit antioxidant properties, prevent damage to DNA and proteins induced by reactive oxygen species and protect mice against injuries caused by radiation-induced oxidative stress. Nanomedicine. 2019;15(1):37–46.
   PubMed Web of Science ®Google Scholar
• Baati T, Bourasset F, Gharbi N, et al. The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene. Biomaterials. 2012;33(19):4936–4946.
   PubMed Web of Science ®Google Scholar
• Qian B, Wang C, Zeng Z, Ren Y, Li D, Song JL. Ameliorative Effect of Sinapic Acid on Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in Kunming (KM) Mice. Oxid Med Cell Longev. 2020;2020:8393504.
   PubMed Web of Science ®Google Scholar
• Balaha M, Kandeel S, Elwan W. Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats. Life Sci. 2016;146:40–51.
   PubMed Web of Science ®Google Scholar
• Molina-Cuevas V, Ravelo-Calzado Y, Zamora-Rodriguez Z, et al. [Effects in rats of bee-wax alcohols (D-002) on ulcerative colitis induced by dextran sulfate and ethanol]. Rev Peru Med Exp Salud Publica. 2017;34(2):176–182. Chinese.
   PubMedGoogle Scholar
• Byelinska IV, Kuznietsova HM, Dziubenko NV, et al. Effect of capital ES, Cyrillic 60 fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in rats. Mater Sci Eng C Mater Biol Appl. 2018;93:505–517.
   PubMed Web of Science ®Google Scholar
• Liao X, Zhao Z, Li H, et al. Fullerene nanoparticles for the treatment of ulcerative colitis. Sci China Life Sci. 2021;1:54.
   Google Scholar
• Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:1525 11–15 25 14.
   Google Scholar
• Tardieu D, Jaeg JP, Cadet J, Embvani E, Corpet DE, Petit C. Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in rat colonic mucosa. Cancer Lett. 1998;134(1):1–5.
   PubMed Web of Science ®Google Scholar
• Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr. 2010;103(6):824–832.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Lu X, Man C, et al. Lactobacillus acidophilus induces cytokine and chemokine production via NF-kappaB and p38 mitogen-activated protein kinase signaling pathways in intestinal epithelial cells. Clin Vaccine Immunol. 2012;19(4):603–608.
   PubMedGoogle Scholar
• Lee Y-M, Lee K-S, Kim D-K. Aqueous Extract of Schizandra chinensis Suppresses Dextran Sulfate Sodiuminduced Generation of IL-8 and ROS in the Colonic Epithelial Cell Line HT-29. Natural Product Sci. 2009;15(4):185–191.
   Google Scholar
• Sands BE, Kaplan GG. The role of TNFalpha in ulcerative colitis. J Clin Pharmacol. 2007;47(8):930–941.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen W. Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis. Exp Ther Med. 2017;14(3):2271–2276.
   PubMed Web of Science ®Google Scholar
• Yin Q, Pi X, Jiang Y, et al. An immuno-blocking agent targeting IL-1beta and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice. Inflammation. 2021;44(5):1724–1736.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol. 1999;94(3):704–712.
   PubMed Web of Science ®Google Scholar
• Walana W, Ye Y, Li M, et al. IL-8 antagonist, CXCL8 (3-72)K11R/G31Pcoupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis. Biomed Pharmacother. 2018;103:253–261.
   PubMed Web of Science ®Google Scholar
• Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013;19(1):115–123.
   PubMed Web of Science ®Google Scholar
• Ruan W, Engevik M, Chang-Graham A, Hyser J, Versalovic J. 7 Lactobacillus reuteri suppresses pro-inflammatory driven reactive oxygen species in vitro in human intestinal epithelial cells and in vivo in a TNBS colitis mouse model. Inflamm Bowel Dis. 2020;26(Supplement_1):S41–S41.
   Web of Science ®Google Scholar